Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000035

President & CEO sold 796,765 shares at $4.83 ($3,848,375)

  • President & CEO acquired 796,765 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ahn Mark J President & CEO 2014-01-27 Option exercise +50,000 $2.31 $115,500 163,764 D
Ahn Mark J President & CEO 2014-01-27 Option exercise +100,000 $1.38 $138,000 263,764 D
Ahn Mark J President & CEO 2014-01-27 Option exercise +324,890 $1.38 $448,348 588,654 D
Ahn Mark J President & CEO 2014-01-27 Option exercise +200,000 $0.72 $144,000 788,654 D
Ahn Mark J President & CEO 2014-01-27 Option exercise +121,875 $1.71 $208,406 918,529 D
Ahn Mark J President & CEO 2014-01-27 Sale −796,765 $4.83 $3,848,375 113,764 D
Derivatives
Ahn Mark J President & CEO 2014-01-27 Option exercise · Stock Option −50,000 0 D
Ahn Mark J President & CEO 2014-01-27 Option exercise · Stock Option −100,000 0 D
Ahn Mark J President & CEO 2014-01-27 Option exercise · Stock Option −324,890 25,110 D
Ahn Mark J President & CEO 2014-01-27 Option exercise · Stock Option −200,000 200,000 D
Ahn Mark J President & CEO 2014-01-27 Option exercise · Stock Option −121,875 423,173 D
Open-market sales · 796,765 sh · avg $4.83 · $3,848,375
Loading xslF345X03/primary_doc.xml…